Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
Apr 2008 - Anticancer Res.; 28(1B):0250-7005 [PMID:18383873]
[Kondo H] [Hazama S] [Kawaoka T] [Yoshino S] [Yoshida S] [Tokuno K] [Takashima M] [Ueno T] [Hinoda Y] [Oka M]

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
Jun 2005 - Clin. Cancer Res.; 11(11):1078-0432 [PMID:15930352]
[Yamanaka R] [Homma J] [Yajima N] [Tsuchiya N] [Sano M] [Kobayashi T] [Yoshida S] [Abe T] [Narita M] [Takahashi M] [Tanaka R]